|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
|||||||||||||||
|
|||||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=sACAF20FC-5EB4-11EF-A003-65F584CE164B&I=39IZM&T=&OP=Display&O=html&O1=15675378&O2=954925415942&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DIndeno%255B1%252C2-b%255Dpyrazin-2%252C3-diones%253A%2520a%2520new%2520class%2520of%2520antagonists%2520at%2520the%2520glycine%2520site%2520of%2520the%2520NMDA%2520receptor%2520with%2520potent%2520in%2520vivo%2520activity%26rft.au%3DBohme%252C%2520G%2520A%26rft.au%3DBoireau%252C%2520A%26rft.au%3DJimonet%252C%2520P%26rft.au%3DRibeill%252C%2520Y%26rft.date%3D2000-06-15%26rft.eissn%3D1520-4804%26rft.epage%3D2381%26rft.externalDBID%3DNO_FULL_TEXT%26rft.genre%3Darticle%26rft.issn%3D0022-2623%26rft.issue%3D12%26rft.jtitle%3DJournal%2520of%2520medicinal%2520chemistry%26rft.spage%3D2371%26rft.volume%3D43%26rft_id%3Dinfo%253Adoi%252F10.1021%252Fjm990957g%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-AMERICAN_CHEMICAL_SOCIETY_JOURNALS_IJS_KILJ_LCL-getFullTxt-object,2-AMERICAN_CHEMICAL_SOCIETY_JOURNALS_PNG_LCL-getFullTxt-object,3-DOI-getDOI-object,4-COBIB_SI_LCL-getHolding-object,5-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,6-NCBI_PUBMED_FREE-getAbstract-object,7-ISI_WEB_OF_SCIENCE-getAuthor-object,8-ISI_JOURNAL_CITATION_REPORTS_SCIENCE_EDITION-getCitedJournal-object,9-REFWORKS_EXPORT_TOOL-getReference-object,10-SHERPA_RoMEO_LCL-getWebService-object,11-GOOGLE_SCHOLAR_FREE-getWebSearch-object,12-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.832013&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15675378-sACAF20FC-5EB4-11EF-A003-65F584CE164B" timestamp="2024-08-20T07:25:56Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:954925415942</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Indeno[1,2-b]pyrazin-2,3-diones: A New Class of Antagonists at the Glycine Site of the NMDA Receptor with Potent in Vivo Activity</jnl:atitle>
<jnl:jtitle>Journal of Medicinal Chemistry</jnl:jtitle>
<jnl:date>2000-06-01</jnl:date>
<jnl:spage>2371</jnl:spage>
<jnl:epage>2381</jnl:epage>
<jnl:coden>JMCMAR</jnl:coden>
<jnl:issn>0022-2623</jnl:issn>
<jnl:volume>43</jnl:volume>
<jnl:issue>12</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>1520-4804</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:coden>JMCMAR</jnl:coden>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:5b81bbf3a0deab70e4c5a13b7b91201a7c60883b</ctx:identifier>
<ctx:identifier>urn:UUID:sACAF20FC-5EB4-11EF-A003-65F584CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)